Literature DB >> 30773442

PET-CT reveals increased intestinal glucose uptake after gastric surgery.

Elisa Franquet1, George Watts1, Gerald M Kolodny1, Allison B Goldfine2, Mary-Elizabeth Patti3.   

Abstract

BACKGROUND: Mechanisms of metabolic improvement after bariatric surgery remain incompletely understood. Intestinal glucose uptake is increased after gastric bypass in rodents, potentially contributing to reduced blood glucose and type 2 diabetes remission.
OBJECTIVE: We assessed whether intestinal glucose uptake is increased in humans after gastric surgery.
SETTING: University Hospital, United States.
METHODS: In a retrospective, case-control cohort study, positron emission tomography-computerized tomography scans performed for clinical indications were analyzed to quantify intestinal glucose uptake in patients with or without history of gastric surgery. We identified 19 cases, defined as patients over age 18 with prior gastric surgery (Roux-en-Y gastric bypass [n = 10], sleeve gastrectomy [n = 1], or Billroth I [n = 2] or II gastrectomy [n = 6]), and 43 controls without gastric surgery, matched for age, sex, and indication for positron emission tomography-computerized tomography. Individuals with gastrointestinal malignancy or metformin treatment were excluded. Images were obtained 60 minutes after 18F-fluorodeoxyglucose injection (4.2 MBq/kg), and corrected by attenuation; noncontrast low-dose computerized tomography was obtained in parallel. Fused and nonfused images were analyzed; standardized uptake values were calculated for each region by volumes of interest at the region of highest activity.
RESULTS: Both standardized uptake values maximum and mean were significantly increased by 41% to 98% in jejunum, ascending, and transverse colon in patients with prior gastric surgery (P < .05 versus controls).
CONCLUSION: Intestinal glucose uptake is increased in patients with prior gastric surgery. Prospective studies are important to dissect the contributions of weight loss, dietary factors, and systemic metabolism, and to determine the relationship with increased insulin-independent glucose uptake and reductions in glycemia.
Copyright © 2019 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  18D-FDG PET-CT; Gastrointestinal surgery; Glucose metabolism; Intestinal glucose uptake; Intestine

Mesh:

Substances:

Year:  2019        PMID: 30773442      PMCID: PMC7008494          DOI: 10.1016/j.soard.2019.01.018

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  29 in total

Review 1.  GLP-2: A POORLY UNDERSTOOD MEDIATOR ENROLLED IN VARIOUS BARIATRIC/METABOLIC SURGERY-RELATED PATHOPHYSIOLOGIC MECHANISMS.

Authors:  Everton Cazzo; Martinho Antonio Gestic; Murillo Pimentel Utrini; Felipe David Mendonça Chaim; Bruno Geloneze; José Carlos Pareja; Elinton Adami Chaim; Daniéla Oliveira Magro
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

2.  Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.

Authors:  Jean-Baptiste Cavin; Anne Couvelard; Rachida Lebtahi; Robert Ducroc; Konstantinos Arapis; Eglantine Voitellier; Françoise Cluzeaud; Laura Gillard; Muriel Hourseau; Nidaa Mikail; Lara Ribeiro-Parenti; Nathalie Kapel; Jean-Pierre Marmuse; André Bado; Maude Le Gall
Journal:  Gastroenterology       Date:  2015-10-23       Impact factor: 22.682

3.  Intestinal Glycolysis Visualized by FDG PET/CT Correlates With Glucose Decrement After Gastrectomy.

Authors:  Cheol Ryong Ku; Narae Lee; Jae Won Hong; In Gyu Kwon; Woo Jin Hyung; Sung Hoon Noh; Eun Jig Lee; Mijin Yun; Arthur Cho
Journal:  Diabetes       Date:  2016-11-30       Impact factor: 9.461

4.  Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia.

Authors:  M E Patti; G McMahon; E C Mun; A Bitton; J J Holst; J Goldsmith; D W Hanto; M Callery; R Arky; V Nose; S Bonner-Weir; A B Goldfine
Journal:  Diabetologia       Date:  2005-09-30       Impact factor: 10.122

5.  Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Giuseppe Nanni; Marco Castagneto; Stefan Bornstein; Francesco Rubino
Journal:  Lancet       Date:  2015-09-05       Impact factor: 79.321

6.  Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery.

Authors:  Silvia Morbelli; Cecilia Marini; Gian Franco Adami; Nobuyuki Kudomi; Giovanni Camerini; Patricia Iozzo; Michela Massollo; Selene Capitanio; Samanta Bodrato; Maria Teresa Verardi; Francesco Papadia; Renzo Cordera; Juhani Knuuti; Nicola Scopinaro; Gianmario Sambuceti
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

7.  Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scans.

Authors:  Elisa Franquet; Mathew R Palmer; Anne E Gifford; Daryl J Selen; Yih-Chieh S Chen; Neda Sedora-Roman; Robin M Joyce; Gerald M Kolodny; Alan C Moss
Journal:  Nucl Med Commun       Date:  2014-10       Impact factor: 1.690

8.  Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug.

Authors:  Tamer Ozülker; Filiz Ozülker; Meral Mert; Tevfik Ozpaçaci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-27       Impact factor: 9.236

9.  Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery.

Authors:  Jaakko Mäkinen; Jarna C Hannukainen; Anna Karmi; Heidi M Immonen; Minna Soinio; Lassi Nelimarkka; Nina Savisto; Mika Helmiö; Jari Ovaska; Paulina Salminen; Patricia Iozzo; Pirjo Nuutila
Journal:  Diabetologia       Date:  2015-01-29       Impact factor: 10.122

10.  Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.

Authors:  Kristoffer Forslund; Falk Hildebrand; Trine Nielsen; Gwen Falony; Emmanuelle Le Chatelier; Shinichi Sunagawa; Edi Prifti; Sara Vieira-Silva; Valborg Gudmundsdottir; Helle K Pedersen; Manimozhiyan Arumugam; Karsten Kristiansen; Anita Yvonne Voigt; Henrik Vestergaard; Rajna Hercog; Paul Igor Costea; Jens Roat Kultima; Junhua Li; Torben Jørgensen; Florence Levenez; Joël Dore; H Bjørn Nielsen; Søren Brunak; Jeroen Raes; Torben Hansen; Jun Wang; S Dusko Ehrlich; Peer Bork; Oluf Pedersen
Journal:  Nature       Date:  2015-12-02       Impact factor: 49.962

View more
  3 in total

1.  Foregut Exclusion Enhances Incretin and Insulin Secretion After Roux-en-Y Gastric Bypass in Adults With Type 2 Diabetes.

Authors:  John P Kirwan; Christopher L Axelrod; Emily L Kullman; Steven K Malin; Wagner S Dantas; Kathryn Pergola; Juan Pablo Del Rincon; Stacy A Brethauer; Sangeeta R Kashyap; Philip R Schauer
Journal:  J Clin Endocrinol Metab       Date:  2021-09-27       Impact factor: 5.958

2.  Glycemic Patterns Are Distinct in Post-Bariatric Hypoglycemia After Gastric Bypass (PBH-RYGB).

Authors:  Daniel Lee; Jonathan M Dreyfuss; Amanda Sheehan; Alexa Puleio; Christopher M Mulla; Mary Elizabeth Patti
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

3.  Characterization of one anastomosis gastric bypass and impact of biliary and common limbs on bile acid and postprandial glucose metabolism in a minipig model.

Authors:  Camille Marciniak; Oscar Chávez-Talavera; Robert Caiazzo; Thomas Hubert; Lorea Zubiaga; Gregory Baud; Audrey Quenon; Amandine Descat; Emmanuelle Vallez; Jean François Goossens; Mostafa Kouach; Vincent Vangelder; Mathilde Gobert; Mehdi Daoudi; Bruno Derudas; Pascal Pigny; André Klein; Valéry Gmyr; Violeta Raverdy; Sophie Lestavel; Blandine Laferrère; Bart Staels; Anne Tailleux; François Pattou
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-01-25       Impact factor: 4.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.